(1) An online prescriber may only prescribe, an online contract pharmacy may only dispense, and an Internet facilitator may only facilitate the prescribing and dispensing of, non-controlled, legend drugs: (a) that have been approved by the Food and Drug Administration; (b) that are prescribed to treat the condition for which the drug was approved, within the drug manufacturer's guidelines; (c) that are specifically approved by the division for online prescribing by administrative rule adopted in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act; (d) that are prescribed for a person who is: (i) 18 years of age or older; or (ii) at least 16 years of age: (A) if permitted by the state or country in which the patient will receive the drug; (B) with parental consent, if required by the state or country in which the patient will receive the drug; and (C) only if the prescription is for a hormonal based contraceptive; and (e) to a person who is located in another country, if the country is designated by the division, by administrative rule, as a country with a regulatory framework for prescribing and dispensing of drugs.

(a) that have been approved by the Food and Drug Administration;

(b) that are prescribed to treat the condition for which the drug was approved, within the drug manufacturer's guidelines;

(c) that are specifically approved by the division for online prescribing by administrative rule adopted in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act;

(d) that are prescribed for a person who is: (i) 18 years of age or older; or (ii) at least 16 years of age: (A) if permitted by the state or country in which the patient will receive the drug; (B) with parental consent, if required by the state or country in which the patient will receive the drug; and (C) only if the prescription is for a hormonal based contraceptive; and

(i) 18 years of age or older; or

(ii) at least 16 years of age: (A) if permitted by the state or country in which the patient will receive the drug; (B) with parental consent, if required by the state or country in which the patient will receive the drug; and (C) only if the prescription is for a hormonal based contraceptive; and

(A) if permitted by the state or country in which the patient will receive the drug;

(B) with parental consent, if required by the state or country in which the patient will receive the drug; and

(C) only if the prescription is for a hormonal based contraceptive; and

(e) to a person who is located in another country, if the country is designated by the division, by administrative rule, as a country with a regulatory framework for prescribing and dispensing of drugs.

(2) If, after January 1, 2010, the Food and Drug Administration issues a clinical black box warning with respect to any drug approved by the board under Subsection (1), the division shall determine what action, if any, is necessary to protect the public health or welfare as a result of the black box warning.